Safety and Efficacy of APRIL-BAFF-Bicephali CAR-T in Relapsed, Refractory Multiple Myeloma

Conditions: Multiple Myeloma Interventions: Other: APRIL-BAFF-Bicephali CAR-T cells Sponsors: Xuzhou Medical University; Yake Biotechnology Ltd. Recruiting

https://clinicaltrials.gov/study/NCT06132711

Source: ClinicalTrials.gov - November 15, 2023 Category: Research Source Type: clinical trials

More News: Biotechnology | Myeloma | Research